Lawmakers and regulators in Washington are considering how to regulate artificial intelligence (AI) in health care, but industry experts believe there is a risk of overregulation. The impact of AI on health care is significant, with the FDA approving over 692 AI products. Government policymakers are already behind and struggling to keep up. There is an increased number of lobbying activities in the AI industry, as well as a need for transparency and privacy regulations. Challenges include the evolving nature of AI and the potential for magnifying existing healthcare biases. AI experts and FDA officials emphasize the need for transparent, monitored algorithms in the long term.
Source link
‘Behind the Times’: Washington Tries to Catch Up With AI’s Use in Health Care
